Govindan R - Search Results

1

Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer.

Spigel DR, Ervin TJ, Ramlau RA, Daniel DB, Goldschmidt JH Jr, Blumenschein GR Jr, Krzakowski MJ, Robinet G, Godbert B, Barlesi F, Govindan R, Patel T, Orlov SV, Wertheim MS, Yu W, Zha J, Yauch RL, Patel PH, Phan SC, Peterson AC. Spigel DR, et al. Among authors: govindan r. J Clin Oncol. 2013 Nov 10;31(32):4105-14. doi: 10.1200/JCO.2012.47.4189. Epub 2013 Oct 7. J Clin Oncol. 2013. PMID: 24101053 Free PMC article. Clinical Trial.

2

Practical issues in the management of the patient with small cell lung cancer.

Govindan R, Ihde DC. Govindan R, et al. Chest Surg Clin N Am. 1997 Feb;7(1):167-81. Chest Surg Clin N Am. 1997. PMID: 9001763 Review.

3

Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation.

Arquette M, Wasserman T, Govindan R, Garfield D, Senzer N, Gillenwater H, Socinski M. Arquette M, et al. Among authors: govindan r. Semin Radiat Oncol. 2002 Jan;12(1 Suppl 1):59-61. doi: 10.1053/srao.2002.31375. Semin Radiat Oncol. 2002. PMID: 11917286 Clinical Trial.

4

Management of patients with non-small cell lung cancer and poor performance status.

Govindan R. Govindan R. Curr Treat Options Oncol. 2003 Feb;4(1):55-9. doi: 10.1007/s11864-003-0031-x. Curr Treat Options Oncol. 2003. PMID: 12525279 Review.

5

Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of response.

Vollmer RT, Govindan R, Graziano SL, Gamble G, Garst J, Kelley MJ, Christenson RH. Vollmer RT, et al. Among authors: govindan r. Clin Cancer Res. 2003 May;9(5):1728-33. Clin Cancer Res. 2003. PMID: 12738727

6

Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC.

Rocha Lima CM, Rizvi NA, Zhang C, Herndon JE 2nd, Crawford J, Govindan R, King GW, Green MR; Cancer Leukemia Group B. Rocha Lima CM, et al. Among authors: govindan r. Ann Oncol. 2004 Mar;15(3):410-8. doi: 10.1093/annonc/mdh104. Ann Oncol. 2004. PMID: 14998842 Free article. Review.

7

Cetuximab in advanced non-small cell lung cancer.

Govindan R. Govindan R. Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4241s-4244s. doi: 10.1158/1078-0432.CCR-040015. Clin Cancer Res. 2004. PMID: 15217966 Review.

8

Single agent gefitinib as first line therapy in patients with advanced non-small cell lung cancer: Washington University experience.

Kommareddy A, Coplin MA, Gao F, Behnken D, Romvari E, Read W, Govindan R. Kommareddy A, et al. Among authors: govindan r. Lung Cancer. 2004 Aug;45(2):221-5. doi: 10.1016/j.lungcan.2004.01.022. Lung Cancer. 2004. PMID: 15246194

9

Differential prognostic impact of comorbidity.

Read WL, Tierney RM, Page NC, Costas I, Govindan R, Spitznagel EL, Piccirillo JF. Read WL, et al. Among authors: govindan r. J Clin Oncol. 2004 Aug 1;22(15):3099-103. doi: 10.1200/JCO.2004.08.040. J Clin Oncol. 2004. PMID: 15284260

10

Positron emission tomography in limited-stage small-cell lung cancer: a prospective study.

Bradley JD, Dehdashti F, Mintun MA, Govindan R, Trinkaus K, Siegel BA. Bradley JD, et al. Among authors: govindan r. J Clin Oncol. 2004 Aug 15;22(16):3248-54. doi: 10.1200/JCO.2004.11.089. J Clin Oncol. 2004. PMID: 15310768 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

654 results

Search Page

Filters